ImmunoGen (IMGN)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Oct 26, 2012)8-K (Aug 3, 2012)8-K (Jul 12, 2012)8-K (Jun 19, 2012)8-K (Apr 27, 2012)8-K (Feb 2, 2012)8-K (Jan 27, 2012)8-K (Dec 20, 2011)8-K (Nov 29, 2011)8-K (Nov 9, 2011)8-K (Oct 27, 2011)8-K (Sep 26, 2011)8-K (Aug 3, 2011)8-K (Jul 28, 2011)8-K (May 27, 2011)8-K (May 20, 2011)8-K (Apr 28, 2011)8-K (Feb 22, 2011)8-K (Jan 27, 2011)8-K (Dec 23, 2010)8-K (Dec 3, 2010)8-K (Nov 18, 2010)8-K (Oct 28, 2010)8-K (Sep 24, 2010)8-K (Aug 4, 2010)8-K (Jul 7, 2010)8-K (Jun 30, 2010)8-K (May 7, 2010)8-K (Apr 29, 2010)8-K (Jan 28, 2010)8-K (Dec 9, 2009)8-K (Dec 7, 2009)8-K (Oct 29, 2009)8-K (Aug 6, 2009)8-K (Jun 18, 2009)8-K (Jun 12, 2009)8-K (Apr 30, 2009)8-K (Jan 29, 2009)8-K (Jan 12, 2009)8-K (Jan 5, 2009)8-K (Dec 12, 2008)8-K (Dec 3, 2008)8-K (Nov 14, 2008)8-K (Nov 4, 2008)8-K (Oct 27, 2008)8-K (Oct 15, 2008)8-K (Sep 30, 2008)8-K (Sep 5, 2008)8-K (Aug 7, 2008)8-K (Aug 1, 2008)8-K (Jul 31, 2008)8-K (Jul 15, 2008)8-K (Jun 23, 2008)8-K (Jun 9, 2008)8-K (May 1, 2008)8-K (Mar 12, 2008)8-K (Jan 31, 2008)8-K (Dec 17, 2007)8-K (Nov 30, 2007)8-K (Nov 19, 2007)8-K (Nov 1, 2007)8-K (Oct 25, 2007)8-K (Oct 17, 2007)8-K (Aug 9, 2007)8-K (Aug 1, 2007)8-K (Jul 31, 2007)8-K (Jul 26, 2007)8-K (Jun 5, 2007)8-K (May 18, 2007)8-K (May 4, 2007)8-K (May 3, 2007)8-K (May 2, 2007)8-K (Apr 6, 2007)8-K (Mar 23, 2007)8-K (Mar 9, 2007)8-K (Feb 5, 2007)8-K (Feb 1, 2007)8-K (Dec 28, 2006)8-K (Dec 15, 2006)8-K (Dec 11, 2006)8-K (Dec 6, 2006)8-K (Nov 15, 2006)8-K (Nov 13, 2006)8-K (Nov 8, 2006)8-K (Nov 2, 2006)8-K (Oct 19, 2006)8-K (Oct 4, 2006)8-K (Sep 11, 2006)8-K (Sep 5, 2006)8-K (Aug 10, 2006)8-K (Jul 12, 2006)8-K (Jun 13, 2006)8-K (May 10, 2006)8-K (May 4, 2006)8-K (Mar 30, 2006)8-K (Feb 7, 2006)8-K (Feb 2, 2006)8-K (Jan 31, 2006)8-K (Jan 26, 2006)8-K (Dec 20, 2005)8-K (Dec 13, 2005)8-K (Nov 16, 2005)8-K (Nov 14, 2005)8-K (Nov 4, 2005)8-K (Nov 3, 2005)8-K (Sep 7, 2005)8-K (Aug 31, 2005)8-K (Aug 11, 2005)8-K (Jul 26, 2005)8-K (Jun 24, 2005)8-K (Jun 16, 2005)8-K (Jun 10, 2005)8-K (May 17, 2005)8-K (May 9, 2005)8-K (May 5, 2005)8-K (May 3, 2005)8-K (Apr 28, 2005)8-K (Apr 19, 2005)8-K (Apr 18, 2005)8-K (Mar 31, 2005)8-K (Mar 17, 2005)8-K (Feb 9, 2005)8-K (Feb 3, 2005)8-K (Jan 7, 2005)8-K (Dec 28, 2004)8-K (Nov 4, 2004)8-K (Oct 27, 2004)8-K (Oct 6, 2004)8-K (Aug 12, 2004)8-K (Jun 22, 2004)8-K (May 27, 2004)8-K (May 17, 2004)8-K (May 13, 2004)8-K (Feb 12, 2004)8-K (Nov 6, 2003)8-K (Oct 1, 2003)8-K (Aug 7, 2003)8-K (Jul 31, 2003)8-K (May 8, 2003)8-K (Feb 12, 2003)8-K (Jan 24, 2003)8-K (Jan 14, 2003)8-K (Nov 21, 2002)8-K (Nov 12, 2002)8-K (Oct 15, 2002)8-K (Sep 20, 2002)8-K (Aug 27, 2002)8-K (Jul 31, 2002)8-K (Jul 11, 2002)8-K (Nov 29, 2001)8-K (Oct 5, 2001)8-K (Sep 7, 2001)8-K (Apr 2, 2001)8-K (Mar 7, 2001)8-K (Nov 16, 2000)8-K (Oct 10, 2000)8-K (Sep 11, 2000)8-K (May 16, 2000)8-K (May 8, 2000)8-K (May 5, 2000)8-K (May 4, 2000)8-K (Jun 2, 1999)8-K (Feb 9, 1999)8-K (Dec 11, 1997)8-K (Aug 1, 1997)8-K (Apr 15, 1997)8-K (Mar 20, 1997)8-K (Jul 15, 1996)8-K (Jun 10, 1996)8-K (Mar 29, 1996)8-K (Aug 30, 1995)

Other

ImmunoGen 8-K 2012

Documents found in this filing:

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 27, 2012

ImmunoGen, Inc.

(Exact name of registrant as specified in its charter)

Massachusetts		0-17999		04-2726691
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

830 Winter Street, Waltham, MA 02451

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (781) 895-0600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 2.02 — RESULTS OF OPERATION AND FINANCIAL CONDITION

On April 27, 2012, ImmunoGen, Inc. (Nasdaq: IMGN) issued a press release to announce the company’s financial results for the quarter ended March 31, 2012. The press release announcing financial results for the quarter ended March 31, 2012 is included as Exhibit 99.1 and incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d): The following exhibit is being furnished herewith:

Exhibit No.		Exhibit

99.1		Press Release of ImmunoGen, Inc. dated April 27, 2012

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ImmunoGen, Inc.
	(Registrant)

Date: April 27, 2012	/s/ Gregory Perry

	Gregory Perry
	Executive Vice President and Chief Financial Officer

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

ImmunoGen (IMGN)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: